{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:45:20Z","timestamp":1791909920714,"version":"4.3.4"},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.euf.2016.11.018","type":"journal-article","created":{"date-parts":[[2016,12,15]],"date-time":"2016-12-15T17:58:59Z","timestamp":1481824739000},"page":"591-598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Longitudinal Changes in Serum Levels of Testosterone and Luteinizing Hormone in Testicular Cancer Patients after Orchiectomy Alone or Bleomycin, Etoposide, and Cisplatin"],"prefix":"10.1016","volume":"4","author":[{"given":"Mikkel","family":"Bandak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Juul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Lauritsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Gry Gundgaard","family":"Kier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette Saks\u00f8","family":"Mortensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gedske","family":"Daugaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2016.11.018_bib0095","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1200\/JCO.2013.51.2715","article-title":"Longitudinal serum testosterone, luteinizing hormone, and follicle-stimulating hormone levels in a population-based sample of long-term testicular cancer survivors","volume":"32","author":"Sprauten","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euf.2016.11.018_bib0100","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/0277-5379(91)90298-R","article-title":"Prediction of long-term gonadal toxicity after standard treatment for testicular cancer","volume":"27","author":"Aass","year":"1991","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.euf.2016.11.018_bib0105","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1530\/EJE-07-0684","article-title":"Risk factors for post-treatment hypogonadism in testicular cancer patients","volume":"158","author":"Eberhard","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.euf.2016.11.018_bib0110","doi-asserted-by":"crossref","DOI":"10.1111\/andr.12177","article-title":"Testosterone deficiency in testicular cancer survivors - a systematic review and meta-analysis","author":"Bandak","year":"2016","journal-title":"Andrology"},{"key":"10.1016\/j.euf.2016.11.018_bib0115","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0302-2838(03)00263-X","article-title":"Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer","volume":"44","author":"Nord","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2016.11.018_bib0120","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/sj.bjc.6602677","article-title":"Fertility, gonadal and sexual function in survivors of testicular cancer","volume":"93","author":"Huddart","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.euf.2016.11.018_bib0125","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.eururo.2007.05.012","article-title":"The quality of life and hormonal disturbances in testicular cancer survivors in cisplatin era","volume":"52","author":"Wiechno","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2016.11.018_bib0130","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1200\/JCO.2005.02.176","article-title":"The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer","volume":"23","author":"Nuver","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euf.2016.11.018_bib0135","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/1097-0142(20010401)91:7<1297::AID-CNCR1132>3.0.CO;2-Z","article-title":"The impact of chemotherapy on Leydig cell function in long term survivors of germ cell tumors","volume":"91","author":"Gerl","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.euf.2016.11.018_bib0140","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1365-2265.2006.02722.x","article-title":"Primary testicular failure in Klinefelter's syndrome: The use of bivariate luteinizing hormone-testosterone reference charts","volume":"66","author":"Aksglaede","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.euf.2016.11.018_bib0145","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1097\/00004872-199816100-00004","article-title":"Normal values for ambulatory blood pressure and differences between casual blood pressure and ambulatory blood pressure: results from a Danish population survey","volume":"16","author":"Rasmussen","year":"1998","journal-title":"J Hypertens"},{"key":"10.1016\/j.euf.2016.11.018_bib0150","first-page":"4059","article-title":"Inhibin B as a serum marker of spermatogenesis: correlation to differences in sperm concentration and follicle-stimulating hormone levels. A study of 349 Danish men","volume":"82","author":"Jensen","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.euf.2016.11.018_bib0155","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1530\/eje.0.1340431","article-title":"Gonadal function after multimodality treatment in men with testicular germ cell cancer","volume":"134","author":"Palmieri","year":"1996","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.euf.2016.11.018_bib0160","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1210\/jc.2009-2354","article-title":"Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline","volume":"95","author":"Bhasin","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.euf.2016.11.018_bib0165","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/annonc\/mds527","article-title":"Early development of the metabolic syndrome after chemotherapy for testicular cancer","volume":"24","author":"de Haas","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.euf.2016.11.018_bib0170","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/annonc\/mdl372","article-title":"Components of the metabolic syndrome in long-term survivors of testicular cancer","volume":"18","author":"Haugnes","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.euf.2016.11.018_bib0175","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/bjc.2013.226","article-title":"Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors","volume":"109","author":"Willemse","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.euf.2016.11.018_bib0180","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1210\/jc.2015-2460","article-title":"The association of reproductive hormone levels and all-cause, cancer and cardiovascular disease mortality in men","volume":"100","author":"Agergaard Holmboe","year":"2015","journal-title":"J Clin Endocrinol Metab"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456916301766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456916301766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:48:22Z","timestamp":1762498102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456916301766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S2405456916301766"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2016.11.018","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal Changes in Serum Levels of Testosterone and Luteinizing Hormone in Testicular Cancer Patients after Orchiectomy Alone or Bleomycin, Etoposide, and Cisplatin","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2016.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}